Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home News room Press releases 2004
Press releases

2004

22/11/2004
ABLYNX APPOINTS EDWIN MOSES AS CHAIRMAN OF THE BOARD OF DIRECTORS

20/09/2004
ABLYNX AND GENENCOR FORM ONCOLOGY COLLABORATION

19/07/2004
ABLYNX AND PROCTER & GAMBLE FORM NANOBODY™ DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP

06/04/2004
ABLYNX CLOSES €25 MILLION SERIES B FINANCING

Press releases

News archive

Email alerts

If you would like to receive updates on the company news, please
click here